A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
April 16 2024 - 1:58PM
Business Wire
Medisca, a global company specializing in personalized
pharmaceutical solutions, is pleased to announce the appointment of
Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony
Dos Santos and Maria Zaccardo, transition into strategic advisory
roles as Chair and Vice Chair, respectively. Coinciding with the
company’s 35th anniversary, this decision marks a significant
milestone in Medisca’s history.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240416663563/en/
Left to right: Tony Dos Santos, Founder |
Maria Zaccardo, Co-founder | Sanjay D. Goorachurn, CEO (Photo:
Business Wire)
In 1989, Medisca opened its doors as a team of three with two
products and a vision to bridge the gaps in patient care. Today,
Medisca is a global leader in personalized medicine with more than
10 locations spanning 5 countries. Powered by a workforce of over
450 employees, Medisca offers a vast portfolio of more than 2,000
product solutions to meet the needs of diverse healthcare
sectors.
“Over the course of 35 years, Medisca has seen remarkable
development, grounded in its people and dynamic entrepreneurial
culture,” said Dos Santos. “With the addition of Sanjay’s unique
set of experiences and skillset, we are confident that this marks
the beginning of a new chapter for Medisca.”
As a seasoned intellectual property lawyer with over 30 years of
experience, Goorachurn is regarded as one of the world’s leading IP
strategists working closely with senior executives of private and
public companies on maximizing the commercial value of a company’s
innovation and IP assets. It is Goorachurn’s distinct expertise and
first-hand experience in implementing transformative growth for
complex and global companies that drew Dos Santos and Zaccardo to
him back in 2016, when he joined the Medisca team as a strategic
advisor.
“Sanjay’s history with Medisca was an essential element that led
to our decision to bring him on as our new CEO,” said Dos Santos.
“Over the last 8 years, Sanjay has built authentic relationships
with many Medisca people and coached us through some very
successful wins, including the advancement and protection of our
key innovations. It was critical to us that the company’s next CEO
be someone who not only has the capability to take us forward, but
also shares the same fundamental values that define who we
are.”
“My goal is to preserve the entrepreneurial legacy of Tony and
Maria and carry forward the company’s vision to empower
personalized wellness for all,” said Goorachurn. “My focus will be
centered around empowering Medisca’s people, creating a more
structured infrastructure for strategic growth, building key
partnerships, and continuing to leverage innovative excellence that
sets Medisca apart, while expanding our global presence.”
About Medisca
Founded in 1989, Medisca is a global leader in personalized
medicine and pharmaceutical supply chain solutions, with a vast
portfolio of over 2,000 products completed by a library of 10,000+
proprietary and customized medication formulas, expertise and
services in pharmaceutical compounding, continuing healthcare
education, analytical testing, and more. Providing finely-tuned
solutions to diverse wellness sectors across the globe, Medisca is
bridging the gaps in healthcare and empowering personalized
wellness for all. For more information, visit
www.medisca.com and follow us on LinkedIn,
Facebook, and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240416663563/en/
Medisca Communications communications@medisca.com
1-800-665-6334